The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Multitarget‐Directed Ligands Combining Cholinesterase and Monoamine Oxidase Inhibition with Histamine H3R Antagonism for Neurodegenerative Diseases
Abstract
The therapy of complex neurodegenerative diseases requires the development of multitarget‐directed drugs (MTDs). Novel indole derivatives with inhibitory activity towards acetyl/butyrylcholinesterases and monoamine oxidases A/B as well as the histamine H 3 receptor (H3R) were obtained by optimization of the neuroprotectant ASS234 by incorporating generally accepted H3R pharmacophore motifs. These small‐molecule hits demonstrated balanced activities at the targets, mostly in the nanomolar concentration range. Additional in vitro studies showed antioxidative neuroprotective effects as well as the ability to penetrate the blood–brain barrier. With this promising in vitro profile, contilisant (at 1 mg kg−1 i.p.) also significantly improved lipopolysaccharide‐induced cognitive deficits.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In vivo efficacy studies showed that administration of 36 at 1 mg/kg is able to restore the cognitive deficit in lipopolysaccharide (LPS)-treated mice.120”
From From combinations to multitarget-directed ligands: A continuum in Alzheimer’s disease polypharmacology (2021) · cites this paper as [120]
Citations
Cites
The role of oxidative stress in neurodegenerative diseases
Kim, G. H., Kim, J. E., Rhie, S. J., & Yoon, S. (2015) · Experimental Neurobiology · doi:10.5607/en.2015.24.4.325 · Cited by 1,355
Extending Applicability of the Oxygen Radical Absorbance Capacity (ORAC−Fluorescein) Assay
Dávalos, A., Gómez‐Cordovés, C., & Bartolomé, B. (2003) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf0305231 · Cited by 1,211
Oxidative Stress in Neurodegenerative Diseases
Niedzielska, E., Smaga, I., Gawlik, M., Moniczewski, A., Stankowicz, P., Pera, J., & Filip, M. (2016) · Molecular Neurobiology · doi:10.1007/s12035-015-9337-5 · Cited by 800
The histamine H3 receptor: from discovery to clinical trials with pitolisant
Schwartz, J.-C. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01286.x · Cited by 329
Acetylcholinesterase inhibitors: novel activities of old molecules
Racchi, M. (2004) · Pharmacological Research · doi:10.1016/j.phrs.2003.12.027 · Cited by 291
Bolea, I., Juárez‐Jiménez, J., Rı́os, C. D. L., Chioua, M., Pouplana, R., Luque, F. J., Unzeta, M., Marco, J. L., & Samadi, A. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm200853t · Cited by 220
Self-citationKeynote review: Histamine H3 receptor antagonists reach out for the clinic
Célanire, S., Wijtmans, M., Talaga, P. E., Leurs, R., & de Esch, I. J. P. (2005) · Drug Discovery Today · doi:10.1016/s1359-6446(05)03625-1 · Cited by 210
Fernández‐Bachiller, M. I., Pérez, C., Campillo, N. E., Paez, J. A., González-Muñoz, G. C., Usán, P., García‐Palomero, E., López, M. G., Villarroya, M., Garcı́a, A. G., et al. (2009) · ChemMedChem · doi:10.1002/cmdc.200800414 · Cited by 160
Histamine H3 receptor as a potential target for cognitive symptoms in neuropsychiatric diseases
Sadek, B. S., Saad, A. K., Sadeq, A. S., Jalal, F. Y., & Stark, H. (2016) · Behavioural Brain Research · doi:10.1016/j.bbr.2016.06.051 · Cited by 158
Self-citationLigneau, X., Morisset‐Lopez, S., Tardivel‐Lacombe, J., Gbahou, F., Ganellin, C. R., Stark, H., Schunack, W. G., Schwartz, J., & Arrang, J. (2000) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703712 · Cited by 149
Self-citation
Research works printed but not linked: 1
- Petroianu G., 2006, Pharmazie, 61, 179
Cited by
Sorted by citations
A perspective on multi‐target drug discovery and design for complex diseases
Ramsay, R. R., Popović-Nikolić, M. R., Nikolic, K. M., Uliassi, E., & Bolognesi, M. L. (2018) · Clinical and Translational Medicine · doi:10.1186/s40169-017-0181-2 · Cited by 751
Self-citationPolypharmacology by Design: A Medicinal Chemist’s Perspective on Multitargeting Compounds
Proschak, E., Stark, H., & Merk, D. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b00760 · Cited by 498
Self-citationAlbertini, C., Salerno, A., de Sena Murteira Pinheiro, P., & Bolognesi, M. L. (2021) · Medicinal Research Reviews · doi:10.1002/med.21699 · Cited by 179
Oset‐Gasque, M. J., & Marco‐Contelles, J. (2018) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.8b00069 · Cited by 160
Self-citationPolymeric Nanoparticles for Nasal Drug Delivery to the Brain: Relevance to Alzheimer's Disease
Rabiee, N., Ahmadi, S., Afshari, R., Khalaji, S., Rabiee, M., Bagherzadeh, M., Fatahi, Y., Dinarvand, R., Tahriri, M., Tayebi, L., et al. (2020) · Advanced Therapeutics · doi:10.1002/adtp.202000076 · Cited by 144
Metadata
- Authors
- Bautista‐Aguilera, Ó. M., Hagenow, S., Palomino‐Antolin, A., Farré‐Alins, V., Ismaili, L., Joffrin, P., Jimeno, M. L., Soukup, O., Janočková, J., Kalinowsky, L., Proschak, E., Iriepa, I., Moraleda, I., Schwed, J. S., Romero Martínez, A., López‐Muñoz, F., Chioua, M., Egea, J., Ramsay, R. R., Marco‐Contelles, J., & Stark, H.
- Affiliations
- Consejo Superior de Investigaciones Científicas (ES)
- Heinrich Heine University Düsseldorf (DE)
- Instituto de Investigación Sanitaria, Servicio de Farmacología Clínica Hospital Universitario de la Princesa Calle de Diego de León, 62 28006 Madrid Spain
- Hospital Universitario de La Princesa (ES)
- Neurosciences Intégratives et Cliniques EA 481 Université Bourgogne Franche-Comté Rue Ambroise Paré 25000 Besançon France
- University of St Andrews (GB)
- University Hospital Hradec Králové (CZ)
- Goethe University Frankfurt (DE)
- Universidad de Alcalá (ES)
- Departamento de Toxicología y Farmacología Facultad de Veterinaria, UCM Av. Puerta de Hierro, s/n 28040 Madrid Spain
- Universidad Camilo José Cela C/ Castillo de Alarcón, 49 28692 Villanueva de la Cañada Madrid Spain
- Laboratorio de Química Médica Instituto de Química Orgánica General CSIC and Centro de Química Orgánica “Lora-Tamayo”, CSIC C/ Juan de la Cierva 3 28006 Madrid Spain
- Corresponding author
- Egea, Javier
- Stark, Holger
- ORCID
- Venue
- Angewandte Chemie International Edition
- Publisher
- Wiley
- Published
- 2017-09
- Volume
- 56
- Issue
- 41
- Pages
- 12765-12769
- ISSN
- 1433-7851 (ISSN-L)
- 1521-3773
- OpenAlex
- W2751976716
- Cited by
- 105
- References
- 29
- Citations by year
- 2026: 4 · 2025: 10 · 2024: 9 · 2023: 8 · 2022: 13 · 2021: 15 · 2020: 13 · 2019: 17 · 2018: 16
- FWCI
- 9.55
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Angewandte Chemie International Edition (publishedVersion)
- PubMed (publishedVersion)
- DIGITAL.CSIC (Spanish National Research Council (CSIC)) (submittedVersion)
- Publikationsdatenbank der Fraunhofer-Gesellschaft (Fraunhofer-Gesellschaft) (submittedVersion)
- Fraunhofer-Publica (Fraunhofer-Gesellschaft) (submittedVersion)
- St Andrews Research Repository (St Andrews Research Repository) (submittedVersion)
- Funders
- Ministerio de Economía y Competitividad (SAF2012-33304, SAF2015-65586-R)
- Universidad Camilo José Cela (2015-12, 2014-35 and 2015-21)
- Fondo de Investigaciones Sanitarias (CP14/00008, PI16/00735)
- MHCZ-DRO (UHHK 00179906)
- European Cooperation in Science and Technology (CM1103, CM15135)
- Deutsche Forschungsgemeinschaft (PRO 1405/2-2, PRO 1405/4-1, SFB 1039 A07, INST208/664-1)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Cholinesterase and Neurodegenerative Diseases
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Physical Sciences › Chemistry › Organic Chemistry › Heterocyclic Compound Synthesis and Bioactivity
- Keywords
- cholinesterase inhibition, acetylcholinesterase, butyrylcholinesterase, monoamine oxidase inhibition, indole derivatives, neurodegenerative diseases, neuroprotection, antioxidant activity, blood-brain barrier penetration, cognitive impairment
- MeSH terms
- Animals, Antioxidants, Blood-Brain Barrier, Cholinesterase Inhibitors, Humans, Indoles, Ligands, Monoamine Oxidase Inhibitors, Piperidines, Drug Design, Neuroprotective Agents, Neurodegenerative Diseases, Mice, Histamine H3 Antagonists, Cognitive Dysfunction
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
